Gyre Therapeutics
- Market cap
- 746.48M
- P/E (TTM)i
- -33.52
- P/Bi
- 6.92
- EPSi
- 0.02
- Div yieldi
- 0.00%
- 52W posi
- 40%
Anonymous reader poll. Unscientific, not investment advice.
Gyre Therapeutics ended the session at 7.04, down 0.57%. Its market capitalisation is about 746.48M, the #3470 most valuable US-listed company we track. Valuation-wise, the P/E sits at -33.52, 153% below the five-year average of 63.05. Wall Street's 2-analyst consensus lands on Buy, with a price target averaging 19.00 (+170% from here). Against a 52-week band of 5.44-9.42, the shares are currently 40% of the way up.
✦ StockVane Quant Insights how this is computed
- Not yet in the StockVane Momentum strategy's universe - this name needs price history back to 2021 for a reliable signal and doesn't have it yet (most often because it IPO'd or was spun off more recently). This grade is a preliminary blend of valuation, momentum and analyst data, not a Momentum buy/sell call.
- Valuation sits at the 42% percentile of its own 5-year range.
- Price momentum averages -1.4% across the trailing 3-month/1-year windows.
- Analyst consensus across 2 analysts is Buy.
- Recent price momentum is -1.4% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 7.08
- Open
- 7.03
- Day range
- 6.99 - 7.15
- Avg price
- 7.06
- Volume
- 99.19K
- Turnover
- 700.20K
- Turnover ratei
- 0.28%
- Volume ratioi
- 0.64
- Amplitudei
- 2.19%
- 52-week rangei
- 5.44 - 9.42
Valuation
- P/Ei
- 352.00
- P/E (TTM)i
- -33.52
- P/Bi
- 6.92
- EPSi
- 0.02
- Book value / shi
- 1.02
- Net profit
- 2.12M
- Net assets
- 107.94M
Share structure
- Market cap
- 746.48M
- Float capi
- 253.03M
- Shares out
- 106.03M
- Float sharesi
- 35.94M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2006-04-12
25.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+22.57K net over the window
Short interest
- Shares short
- 1.73M
- % of floati
- 1.63%
- Days to coveri
- 19.22
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Gyre Therapeutics (GYRE)?
Gyre Therapeutics last traded at 7.04. The quote on this page refreshes every few seconds while US markets are open.
What is Gyre Therapeutics's market cap?
About 746.48M.
What is the P/E ratio of Gyre Therapeutics?
The trailing twelve-month P/E is -33.52, below its own 5-year average of 63.05 — toward the bottom of its historical range (6.30% percentile). See the Valuation tab for the full history.
Does Gyre Therapeutics pay a dividend?
Gyre Therapeutics does not currently pay a regular dividend.
Is Gyre Therapeutics a buy according to analysts?
The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 19.00, which implies 169.9% upside from the current price. This is not investment advice.
Quote time 2026-10-08 04:06:39 · For reference only, not investment advice and not tailored to your situation.